Clinical Trials Directory

Trials / Completed

CompletedNCT03388567

Evaluation of the Effectiveness of a Continuing Education Program in Community Pharmacies

Evaluation of the Effects of a Drug With Fiscalized Substances Dispensation, Health Education and Pharmacovigilance Continuing Education Program in Community Pharmacies: Study Protocol for a Multicenter, Cluster-randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
360 (actual)
Sponsor
Universidad de Antioquia · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Preventable failures in the drug chain are related to Drugs Problems Related Use and are associated with medication errors (prescription, dispensing, administration or use by the patient or caregiver), including failures In the Medication Supply System (availability and quality). The controlled drugs are those that contain substances regulated by international conventions on drug control. They are important in various fields of medicine, such as pain management, obstetric emergencies, mental disorders such as the treatment of substance dependence, psychiatry and neurology. It has been defined as abuse of drugs the improper use of these for non-medical purposes, and associated with the use without medical prescription, which can produce addiction or psychic or physical dependence.

Detailed description

Experimental study with random assignment of the staff pharmacist of Pharmacies. The staff pharmacists admitted will be followed for 12 months (1 year). The study will make it possible to determine the effect of the continuing education program accompanied by Information and Communication Technologies (ICT).

Conditions

Interventions

TypeNameDescription
OTHERStaff pharmacy whith interventionPharmacists who will receive continuous education through technology and communication tools, as well as accompaniment and advice from a pharmaceutical chemist

Timeline

Start date
2018-12-01
Primary completion
2018-12-01
Completion
2019-12-31
First posted
2018-01-03
Last updated
2020-04-10

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT03388567. Inclusion in this directory is not an endorsement.